Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) EBT (2022 - 2025)

Envoy Medical's EBT history spans 4 years, with the latest figure at -$6.2 million for Q3 2025.

  • For Q3 2025, EBT fell 17.96% year-over-year to -$6.2 million; the TTM value through Sep 2025 reached -$22.4 million, up 14.69%, while the annual FY2024 figure was -$20.1 million, 9.26% down from the prior year.
  • EBT for Q3 2025 was -$6.2 million at Envoy Medical, down from -$5.7 million in the prior quarter.
  • Across five years, EBT topped out at $12.5 million in Q1 2022 and bottomed at -$11.1 million in Q4 2023.
  • The 4-year median for EBT is -$4.9 million (2024), against an average of -$2.1 million.
  • The largest annual shift saw EBT plummeted 867.24% in 2023 before it soared 55.62% in 2024.
  • A 4-year view of EBT shows it stood at -$1.1 million in 2022, then tumbled by 867.24% to -$11.1 million in 2023, then skyrocketed by 55.62% to -$4.9 million in 2024, then decreased by 25.26% to -$6.2 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's EBT are -$6.2 million (Q3 2025), -$5.7 million (Q2 2025), and -$5.6 million (Q1 2025).